- Home
- MBIO vs RBNE Comparison
MBIO vs RBNE Comparison
Compare MBIO & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBIO | RBNE |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 4.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MBIO | RBNE |
|---|---|---|
| Price | $0.57 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.7K | ★ 198.9K |
| Earning Date | 05-13-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $42.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.43 |
| 52 Week High | $1.96 | $8.15 |
Technical Indicators
Market Signals| Indicator | MBIO | RBNE |
|---|---|---|
| Relative Strength Index (RSI) | 34.19 | 49.69 |
| Support Level | $0.53 | $0.83 |
| Resistance Level | $0.82 | $4.57 |
| Average True Range (ATR) | 0.04 | 0.97 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 1.32 | 36.65 |
Price Performance
Historical ComparisonAbout MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
About RBNE Robin Energy Ltd.
Robin Energy Ltd is engaged in the ownership and operation of vessels providing seaborne transportation of refined petroleum products and liquefied petroleum gas (LPG). The company operates in two reportable segments: the Tanker segment and the LPG carrier segment.